Vijaya Diagnostic Q2 profit rises 37.4% to ₹59.5 crore
In short
Vijaya Diagnostic Centre said its Q2 net profit rose 37.4% to ₹59.5 crore.
Revenue climbed 26.7% to ₹255.4 crore, and EBITDA rose 37.8% to ₹112.7 crore. The report says higher test volumes and better margins helped, but it does not give guidance.
What the reporting says
Vijaya Diagnostic Centre reported a 37.4% year-on-year rise in Q2 net profit to ₹59.5 crore, with revenue up 26.7% to ₹255.4 crore, according to the publisher-supplied summary. EBITDA increased 37.8% to ₹112.7 crore and margins expanded 350 basis points to 44.1%, which the headline links to higher test volumes and margin expansion. The snippet does not provide management commentary or forward guidance.
Why it matters
Vijaya Diagnostic Centre posted stronger Q2 numbers, with profit, revenue and EBITDA all rising and margins improving to 44.1%. The report points to higher test volumes and margin expansion, but it does not include management guidance or say whether the results changed the stock price. The immediate impact is mainly on company performance expectations.